Terms: = Ovarian cancer AND ETV5, P41161, 2119, ENSG00000244405, ERM
25 results:
1. Moesin affects the plasma membrane expression and the immune checkpoint function of CD47 in human ovarian clear cell carcinoma.
Ito Y; Kobori T; Urashima Y; Ito T; Hotta K; Obata T
J Reprod Immunol; 2024 Feb; 161():104185. PubMed ID: 38141516
[TBL] [Abstract] [Full Text] [Related]
2. ANGPTL4 functions as an oncogene through regulation of the etv5/CDH5/AKT/MMP9 axis to promote angiogenesis in ovarian cancer.
Liu Y; Yang R; Zhang Y; Zhu Y; Bao W
J Ovarian Res; 2022 Dec; 15(1):131. PubMed ID: 36517864
[TBL] [Abstract] [Full Text] [Related]
3. O-GlcNAcylation regulates lysophosphatidic acid-induced cell migration by regulating erm family proteins.
Song M; Suh PG
FEBS Open Bio; 2022 Jun; 12(6):1220-1229. PubMed ID: 35347892
[TBL] [Abstract] [Full Text] [Related]
4. etv5-mediated upregulation of lncRNA CTBP1-DT as a ceRNA facilitates HGSOC progression by regulating miR-188-5p/MAP3K3 axis.
Liu P; Fu R; Chen K; Zhang L; Wang S; Liang W; Zou H; Tao L; Jia W
Cell Death Dis; 2021 Dec; 12(12):1146. PubMed ID: 34887384
[TBL] [Abstract] [Full Text] [Related]
5. Biological and prognostic value of etv5 in high-grade serous ovarian cancer.
Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
[TBL] [Abstract] [Full Text] [Related]
6. Long-term survival outcome of advanced epithelial ovarian cancer: A single institutional study.
Viral P; Rajanbabu A; Pavithran K; Chithrathara K; Nair IR; Bhaskaran R; Gangadharan P; Vijaykumar DK
Indian J Cancer; 2021; 58(3):342-348. PubMed ID: 33402564
[TBL] [Abstract] [Full Text] [Related]
7. MiR-1307 influences the chemotherapeutic sensitivity in ovarian cancer cells through the regulation of the CIC transcriptional repressor.
Zhou Y; Wang M; Shuang T; Liu Y; Zhang Y; Shi C
Pathol Res Pract; 2019 Oct; 215(10):152606. PubMed ID: 31500928
[TBL] [Abstract] [Full Text] [Related]
8. LPA-induced migration of ovarian cancer cells requires activation of erm proteins via LPA
Park J; Jang JH; Oh S; Kim M; Shin C; Jeong M; Heo K; Park JB; Kim SR; Oh YS
Cell Signal; 2018 Apr; 44():138-147. PubMed ID: 29329782
[TBL] [Abstract] [Full Text] [Related]
9. Dynamic relocalization of NHERF1 mediates chemotactic migration of ovarian cancer cells toward lysophosphatidic acid stimulation.
Oh YS; Heo K; Kim EK; Jang JH; Bae SS; Park JB; Kim YH; Song M; Kim SR; Ryu SH; Kim IH; Suh PG
Exp Mol Med; 2017 Jul; 49(7):e351. PubMed ID: 28684865
[TBL] [Abstract] [Full Text] [Related]
10. Similar expression pattern of NHERF1 and EZRIN in papillary but not in solid areas of human serous ovarian carcinomas.
Demacopulo B; Lema BE; Cabrini RL; Kreimann EL
Acta Histochem; 2016 Oct; 118(8):797-805. PubMed ID: 27823775
[TBL] [Abstract] [Full Text] [Related]
11. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer.
Jaaback K; Johnson N; Lawrie TA
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD005340. PubMed ID: 26755441
[TBL] [Abstract] [Full Text] [Related]
12. BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study.
Gau DM; Lesnock JL; Hood BL; Bhargava R; Sun M; Darcy K; Luthra S; Chandran U; Conrads TP; Edwards RP; Kelley JL; Krivak TC; Roy P
Cell Cycle; 2015; 14(12):1884-92. PubMed ID: 25927284
[TBL] [Abstract] [Full Text] [Related]
13. erm/etv5 and RUNX1/AML1 expression in endometrioid adenocarcinomas of endometrium and association with neoplastic progression.
de Sousa VP; Chaves CB; Huguenin JF; Moreira FC; de Reis BS; Chimelli L; Bergmann A; Simão Tde A; Pinto LF
Cancer Biol Ther; 2014 Jul; 15(7):888-94. PubMed ID: 24756106
[TBL] [Abstract] [Full Text] [Related]
14. High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease.
Bristow RE; Chang J; Ziogas A; Randall LM; Anton-Culver H
Gynecol Oncol; 2014 Feb; 132(2):403-10. PubMed ID: 24361578
[TBL] [Abstract] [Full Text] [Related]
15. Differential expression of p-erm, a marker of cell polarity, in benign and neoplastic oviductal epithelium.
Ning G; Bijron JG; Yuan J; Hirsch MS; McKeon FD; Nucci MR; Crum CP; Xian W
Int J Gynecol Pathol; 2013 Jul; 32(4):345-52. PubMed ID: 23722506
[TBL] [Abstract] [Full Text] [Related]
16. Analysis of gene expression regulated by the etv5 transcription factor in OV90 ovarian cancer cells identifies FOXM1 overexpression in ovarian cancer.
Llauradó M; Majem B; Castellví J; Cabrera S; Gil-Moreno A; Reventós J; Ruiz A
Mol Cancer Res; 2012 Jul; 10(7):914-24. PubMed ID: 22589409
[TBL] [Abstract] [Full Text] [Related]
17. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer.
Jaaback K; Johnson N; Lawrie TA
Cochrane Database Syst Rev; 2011 Nov; (11):CD005340. PubMed ID: 22071822
[TBL] [Abstract] [Full Text] [Related]
18. etv5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells.
Llauradó M; Abal M; Castellví J; Cabrera S; Gil-Moreno A; Pérez-Benavente A; Colás E; Doll A; Dolcet X; Matias-Guiu X; Vazquez-Levin M; Reventós J; Ruiz A
Int J Cancer; 2012 Apr; 130(7):1532-43. PubMed ID: 21520040
[TBL] [Abstract] [Full Text] [Related]
19. Identification of NDRG1-regulated genes associated with invasive potential in cervical and ovarian cancer cells.
Zhao G; Chen J; Deng Y; Gao F; Zhu J; Feng Z; Lv X; Zhao Z
Biochem Biophys Res Commun; 2011 Apr; 408(1):154-9. PubMed ID: 21463610
[TBL] [Abstract] [Full Text] [Related]
20. Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and etv5/erm at the invasive front of endometrial and ovarian carcinoma.
Planagumà J; Liljeström M; Alameda F; Bützow R; Virtanen I; Reventós J; Hukkanen M
Hum Pathol; 2011 Jan; 42(1):57-67. PubMed ID: 20970160
[TBL] [Abstract] [Full Text] [Related]
[Next]
